Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Walmart's Weight-Loss Drug Windfall Is Losing Steam

Walmart Inc. (NASDAQ:WMT) stock fell in Thursday’s premarket session despite the retail giant reporting better-than-expected third-quarter fiscal 2027 results and raising its full-year outlook again. Earnings Snapshot Adjusted earnings of 65 cents per share exceeded analyst expectations of 64 cents. The figure excludes an after-tax loss of 3 cents per share related to equity and other investments…

Walmart's Weight-Loss Drug Windfall Is Losing Steam

Walmart Inc.'s stock dipped in early trading on Thursday, despite the company reporting better-than-expected third-quarter fiscal 2027 results and raising its full-year outlook. Adjusted earnings of 65 cents per share surpassed analyst expectations of 64 cents, while revenue rose 5.2% year-over-year to $188.835 billion. Walmart U.S. net sales grew 3.6% year-over-year to $125 billion, with e-commerce sales increasing 23%.

Membership and other income expanded 20%, driven by a 17% rise in global membership fee revenue. The company repurchased $2.7 billion in shares during the quarter. However, lower fuel margins at Sam's Club U.S. and growing expenses limited the gains. Walmart expects GLP-1 medications to contribute a smaller boost to U.S. comparable sales growth this fiscal year, as unfavorable pricing and shifts in product mix erode their sales contribution.

Written by urgent.news from Benzinga's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at benzinga.com →

More in Finance & Markets

Auction of State Government Securities

The following State Governments have offered to sell stock by way of auction, for an aggregate amount of ₹31,950 Crore (Face Value). Sr. No.

  • ₹31,950 Crore to be raised through auction
  • Ten-day auction starts November 23, 2026
  • 10% of stocks allotted to eligible individuals

More from Thursday 19 November →